Chemed

CHE

Market cap $6.25B

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the third quarter ended September 30, 2025, on Tuesday, October 28, 2025, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Wednesday, October 29, 2025, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call t.

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the Jefferies 2025 Healthcare Services Conference on Tuesday, September 30, 2025, at approximately 1:50 p.m. (CT) at the 1 Hotel in Nashville. The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentatio.

Fresh off the first federal funds rate cut of the year, investors are keeping a close watch over recession indicators. A struggling housing market, warning signs about the labor market, and other metrics may suggest an impending recession, despite the fact that many stocks continue to soar higher.

This is my latest article where I provide predictions of upcoming dividend increases from companies with long-term dividend growth histories. Dividend growth in August was strong, with several companies posting double-digit increases, but September is expected to bring mostly mid-single-digit boosts. Tobacco company Altria continued to grow its dividend, extending its growth streak to 56 years with a 4% increase.

Chemed (CHE) reported earnings 30 days ago. What's next for the stock?

Chemtrade Logistics Income Fund (OTC:CGIFF) Q2 2025 Earnings Conference Call August 15, 2025 10:00 AM ET Company Participants Rohit Bhardwaj - VP of Finance & CFO Scott William Rook - CEO, President & Trustee Conference Call Participants Benjamin Isaacson - Scotiabank Global Banking and Markets, Research Division Gary Ho - Desjardins Securities Inc., Research Division Hamir Patel - CIBC Capital Markets, Research Division Joel Jackson - BMO Capital Markets Equity Research Nelson Ng - RBC Capital Markets, Research Division Steven P. Hansen - Raymond James Ltd.

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed's existing share repurchase program. These shares repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility. The Board of Directors has declared a quarterly cash dividend of 60-cents per share on the Company's capital stock, payab.

MIRAMAR, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- VITAS Healthcare, one of the nation's leading providers of hospice and palliative care, and a subsidiary of Chemed Corporation (NYSE: CHE), today announced that Nicholas M. Westfall will step down as chairman and chief executive officer to pursue other personal and professional opportunities. Joel L. Wherley, president and chief operating officer, was appointed by the Board to succeed Westfall as chief executive officer of VITAS Healthcare.

Chemed Corporation (NYSE:CHE ) Q2 2025 Earnings Conference Call July 30, 2025 10:00 AM ET Company Participants Holley Schmidt - Corporate Participant Kevin J. McNamara - CEO, President & Director Michael D.

Chemed (CHE -9.17%) -- home to hospice care provider Vitas Healthcare and Roto-Rooter -- saw its shares decline 9% as of 1 p.m. ET on Wednesday, according to data provided by S&P Global Market Intelligence.